 Tags:
cancer |
|
|
|
|
|
|
« Back 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 Next » |
|
»
New treatment for liver CANCER
Published 2008-03-31
|
| 
Liver cancer specialists at Jefferson’s Kimmel Cancer Center in Philadelphia are beginning an 18-month study of a new treatment for liver cancer. The therapy entails injecting tiny beads that emit small amounts of radiation into the liver’s main artery while also blocking the blood supply feeding the cancer’s growth.
|
»
Analysis proved a link between breast CANCER risk, smoking, and a specific gene
Published 2008-03-31
|
| 
Women who smoke and have a specific genetic makeup are at significant risk for the development of breast cancer, according to a recent study published by the journal Cancer Epidemiology, Biomarkers and Prevention.
|
»
Breast CANCER Survivors on Dragon boat racing
Published 2008-03-31
|
| 
The best long-term therapy for breast cancer survivors might have nothing to do with doctors or self-help books, a health researcher at McGill University says. Her prescription? Dragon boat racing.
|
»
The same gene in the same CANCER can play a completely different role
Published 2008-03-31
|
| 
Perhaps the only positive spin one can put on the brain cancer glioblastoma is that it's relatively uncommon. Other than that, the news is bad. It is nearly always fatal, it tends to strike people in the prime of their lives, and the limited treatment options have changed little over decades. It's no wonder then that many researchers are determined to find new ways treat this poorly understood type of cancer.
|
»
Novel approach to CANCER could result in better prevention and detection
Published 2008-03-24
|
| 
Researchers at the University of Nebraska Medical Center (UNMC) in Omaha have assisted in a significant discovery – the understanding of a common mechanism of cancer initiation – that could result in better cancer assessment, prevention and detection.
|
»
New Risk Assessment Tool slakes panic about suspected CANCER-causing agents
Published 2008-03-24
|
| 
New research has allayed some panic about suspected cancer-causing agents, such as deodorants, coffee and artificial sweeteners. A risk assessment tool has been developed through the Cancer Control Program at South Eastern Sydney & Illawarra Health (SESIH) by UNSW researcher, Professor Bernard Stewart.
|
»
Researchers provided genetic evidence that ATF2 plays a suppressor role in skin CANCER development
Published 2008-03-24
|
| 
Researchers at the Burnham Institute for Medical Research (Burnham Institute) have provided genetic evidence that Activating Transcription Factor 2 (ATF2) plays a suppressor role in skin cancer development. ATF2 is a protein that regulates gene transcription, which is the first step in the translation of genetic code, in response to extracellular stresses such as ultraviolet light and ionizing radiation.
|
»
Treatment of Pediatric Thyroid CANCER is greatly improved by Early Detection
Published 2008-03-23
|
| 
Efforts to treat pediatric papillary thyroid cancer are greatly improved by detecting the disease as early as possible, making the patient's age the most important factor in determining a prognosis, according to new research published in the February 2008 issue of the journal Otolaryngology -- Head and Neck Surgery.
|
»
Vaccine Booster Gives Persistent Immune Response for lung CANCER recurrence
Published 2008-03-23
|
|
What if we could prevent cancer recurrence for years after surgery by giving simple recall injections every two or three years? This concept may no longer be a fantasy. In a clinical study a team headed by the international Ludwig Institute for Cancer Research (LICR) has shown that a vaccine against a protein found in cancer cells produces an immune response that can be boosted and strengthened with additional vaccine shots. Patients with resected non-small cell lung cancer (NSCLC) were treated with this investigational agent, also known as an Antigen-Specific Cancer Immunotherapeutic (ASCI), in another clinical study conducted by GlaxoSmithKline. The results showed a reduction in risk of cancer recurrence in these patients, a finding that prompted GlaxoSmithKline to initiate the largest ever clinical trial in lung cancer (MAGRIT study).
|
»
Inconclusive Benefits Of Vitamin And Mineral Use Among CANCER Survivors
Published 2008-03-23
|
| 
Use of vitamin and mineral supplements among cancer survivors is widespread, despite inconclusive evidence that such use is beneficial, according to a comprehensive review of scientific literature conducted by researchers at Fred Hutchinson Cancer Research Center and published Feb. 1 in the Journal of Clinical Oncology.
|
»
Breast CANCER Stem Cells Related to BRCA1 Mutation
Published 2008-03-13
|
| 
A new study may explain why women with a mutation in the BRCA1 gene face up to an 85 percent lifetime risk of breast cancer.
|
»
Acute Myeloid Leukemia reduced by Kidney CANCER Drug
Published 2008-03-13
|
| 
A drug used to treat kidney cancer also targets a genetic mutation active in about one third of patients with acute myeloid leukemia (AML), the most common and lethal form of adult leukemia, researchers at The University of Texas M. D. Anderson Cancer Center report in the Jan. 29 edition of the Journal of the National Cancer Institute.
|
»
Colon CANCER And Poor Outcomes Associated With MicroRNAs Expression Patterns
Published 2008-03-13
|
| 
Preliminary research has found an association between certain microRNA expression patterns and poor survival and treatment outcomes for colon cancer.
|
»
Breast CANCER Prognosis Linked To Protein
Published 2008-03-13
|
| 
High levels of the Ki-67 protein are associated with poor prognosis in early breast cancer patients, but it may not able to predict which patients will benefit from additional chemotherapy.
|
»
AIDS Or Cervical CANCER Vaccines May Result From Novel Concept
Published 2008-03-13
|
| 
Creating vaccines to protect people against viral diseases like AIDS, cervical cancer and infectious hepatitis is a delicate balancing act: If the immune system's response to the vaccine is too strong, toxic side effects can kill the patient. If it's not strong enough, the virus will spread faster than the immune system can kill it.
|
»
Women who live in gentrifying neighborhoods to receive late diagnosis of breast CANCER
Published 2008-03-13
|
| 
Women who live in Chicago's gentrifying neighborhoods are more apt to receive a late diagnosis of breast cancer than women who live in poverty-stricken neighborhoods, University of Illinois at Chicago researchers have found.
|
»
Carbon nanotubes are promising for biomedical applications and treating CANCER
Published 2008-03-13
|
| 
Carbon nanotubes-cylinders so tiny that it takes 50,000 lying side by side to equal the width of a human hair-are packed with the potential to be highly accurate vehicles for administering medicines and other therapeutic agents to patients. But a dearth of data about what happens to the tubes after they discharge their medical payloads has been a major stumbling block to progress.
|
»
Liver CANCER Survival Predicted by MicroRNA Molecules
Published 2008-03-13
|
| 
Tiny molecules that help cells regulate which proteins they make might one day help doctors predict which liver-cancer patients are likely to live longer than others, new research suggests.
|
»
Research reveals model for more accurate prediction of the risk of prostate CANCER
Published 2008-03-13
|
| 
Scientists are another step closer to understanding why some people suffer from life-threatening diseases such as cancer. New research reveals a model that may enable more accurate prediction of the risk of prostate cancer progression. By combining the Gleason score (a pathological score given to prostate cancer based on its microscopic appearance) with structured data from biomarker assessments, the researchers have developed a model for predicting the likelihood of prostate cancer virulence.
|
»
Lung CANCER Patient Response To Therapy Predicted by New Discovered Biomarkers
Published 2008-03-13
|
| 
Researchers at UCLA's Jonsson Cancer Center have discovered biomarkers that predict which patients with advanced non-small cell lung cancer will respond to a combination treatment of the anti-inflammatory drug Celebrex and the growth factor receptor blocker Tarceva.
|
|
|
« Back 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 Next » |
